Cefiderocol
Fetroja, Fetcroja (cefiderocol) is a small molecule pharmaceutical. Cefiderocol was first approved as Fetroja on 2019-11-14. It is used to treat bacterial infections, pyelonephritis, and urinary tract infections in the USA. It has been approved in Europe to treat gram-negative bacterial infections. Fetroja's patents are valid until 2035-09-03 (FDA).
| Trade Name | Fetcroja |
|---|---|
| Common Name | Cefiderocol |
| Indication | bacterial infections, gram-negative bacterial infections, pyelonephritis, urinary tract infections |
| Drug Class | Cephalosporins |
